📺 Watch Anna Vernet, Head of Unit for Antitrust Pharma and Health Services, explain the reasons behind today’s decision to fine Teva €462.6 million ⬇️🗣 "With today's decision, the Commission is sanctioning Teva's illegal behavior and ensuring that effective competition can lower prices, benefiting Europe’s patients and healthcare systems."